Form 4 for OGN Organon & Co.
Accepted 2024-04-03 00:00:00 ET · period of report 2024-03-31 · accession 0001821825-24-000047 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-03 | 2024-03-31 | OGN | Nisita Vittorio | Head of Gbl Business Svcs | F - Tax | $18.80 | -2,559 | 21.0K | -11% | -$48.1K |
| DM | 2024-04-03 | 2024-03-31 | OGN | Nisita Vittorio | Head of Gbl Business Svcs | M - OptEx | $0.00 | +7,469 | 19.0K | +65% | $0 |
| DM | 2024-04-03 | 2024-03-31 | OGN | Nisita Vittorio | Head of Gbl Business Svcs | M - OptEx | $0.00 | -7,469 | 9,212 | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-31 | F | D | 981 | $18.80 | 17,991 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-31 | M | A | 4,606 | $0.00 | 22,597 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-31 | M | A | 2,863 | $0.00 | 18,972 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-31 | F | D | 1,578 | $18.80 | 21,019 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2024-03-31 | M | D | 2,863 | $0.00 | 2,863 | D | — · — to — | 2,863 Common Stock | (F1) Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. (F2) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025. |
| 6 | Derivative | Restricted Stock Units | 2024-03-31 | M | D | 4,606 | $0.00 | 9,212 | D | — · — to — | 4,606 Common Stock | (F1) Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. (F3) The Reporting Person was granted RSUs on March 31, 2023. On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026. |